Health Care

Herbalife threw a jab at Bill Ackman as the hedge fund manager and Valeant Pharmaceuticals investor mounted a defense of the drug company.

A front-page WSJ expose casts serious doubt on the efficacy and accuracy of Theranos’ purportedly disruptive blood testing technology.

The recently-enacted 2016 budget act took away some popular Social Security claiming strategies but it gave seniors a reprieve from as much as a 50% increase in their Medicare Part B premiums next year.

Infamous price gouging CEO Martin Shkreli was released on $5 million bond Thursday after being arrested on fraud charges. 

Public Citizen sent a letter to the drug promotion overseer at the Food and Drug Administration urging it to pull ads for five Type 2 diabetes drugs because it claims the ads promote benefits that have not been approved by the agency.

Merck & Co Inc is in talks to acquire Cubist Pharmaceuticals Inc for more than $7 billion in a deal that could be announced as early as next week, the New York Times reported on Friday, citing people briefed on the matter.

Electronic cigarettes may be more tempting to non-smoking youths than conventional cigarettes, a CDC study released Monday shows.

Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May.

The U.S. drugmaker Pfizer is under fire on both sides of the Atlantic as it weighs its next move to buy British rival AstraZeneca.

Endo International PLC has agreed to buy Par Pharmaceutical Holdings Inc. from private-equity firm TPG for about $8 billion in cash and stock, a deal that will help boost its generics business.

The government says drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, from research grants to free lunches and junkets.

Get ready for another round of battles over medical coverage and payment systems between the government, health care providers, and consumers – or is it really just one continuous battle?

Anthem said it will buy rival Cigna in a deal valued at $54.2 billion, creating the largest U.S. health insurer by membership. The deal comes amid consolidation in the health-care industry following the rollout of Obamacare.

Walgreens Boots Alliance Inc. is in advanced talks to buy Rite Aid Corp. in a deal that would unite the nation's second- and third-largest drugstore chains.

A specialty drugmaker said it would sell for less than $1 a version of Daraprim, an anti-infective drug at the heart of allegations of "price gouging" involving Turing Pharmaceuticals after it hiked the price by over 5,000 percent to $750 a pill.

AstraZeneca said on Monday it was in talks with privately held cancer drug developer Acerta Pharma, after the Wall Street Journal reported on Friday it was looking to acquire the business for more than $5 billion.